Latest Tech News
Why do I have critically low CBC, abnormal chemistry, and/or abnormal coagulation results for my patients? Why is the drug level is very high? Why do the results fluctuate and do not correlate with the patient’s condition? These are some of the questions we are frequently asked when it comes to specimens collected from
Over the past couple months, we at Aculabs have been busy revamping both our public as well as our private, websites. With many suggestions, and much input from our clients, we have both modernized, as well as simplified, many sections of our online presence. As you will see by browsing www.aculabs.com, we have
March 6, 2018 - From providing vital diagnostic screenings for a wide range of conditions, to playing a pivotal role in precision medicine, clinical laboratories are a crucial component of America’s health system that drive disease prevention and diagnosis and help guide treatment decisions for patient care. Congress enacted the Protecting Access to Medicare
March 2, 2018 - Aculabs, working in partnership with Abbott industries, is happy to announce the expansion of the i-STAT Point of Care Program. With the successful deployment of 7 devices throughout calendar year 2017, Aculabs is pleased to announce that 10 more sites have committed to utilize the Aculabs i-STAT Point
August 11, 2017 - The Centers for Medicare & Medicaid Services is preparing to implement the Protecting Access to Medicare Act. This requires CMS to collect information about private payor reimbursement from all parts of the laboratory market, and base the Clinical Laboratory Fee Schedule (CLFS) payments on the weighted median of these rates. However,